相关实验视频
Updated: May 5, 2026

An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis
Published on: August 14, 2016
一个突变p53/Smad复合体反对p63以赋予TGFbeta诱导的转移能力
Maddalena Adorno1, Michelangelo Cordenonsi, Marco Montagner
1Department of Histology, Microbiology and Medical Biotechnologies, University of Padua School of Medicine, viale Colombo 3, 35100 Padua, Italy.
转化生长因子β (TGFbeta) 在晚期癌症中从瘤抑制剂转变为前列腺扩散因子. 突变的p53和Ras瘤基因与TGFbeta合作抑制p63,促进转移.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症转移研究 癌症转移研究
背景情况:
- 转化生长因子β (TGFbeta) 在癌症中表现出双重作用,在早期阶段起作用作为瘤抑制剂,并在晚期恶性瘤中起作用为前列腺扩散因子.
- 这种TGFβ功能的转换背后的分子机制在很大程度上是未知的,特别是关于它在癌症进展和转移中的作用.
研究的目的:
- 阐明TGFbeta在晚期癌症中促进细胞迁移,入侵和转移的分子机制.
- 在癌症转移的背景下,研究TGFbeta,突变p53和p63之间的相互作用.
主要方法:
- 研究了TGFβ-依赖细胞迁移和入侵.
- 分析了突变p53/p63蛋白质复合体的形成和Smad参与.
- 评估了p63在三元复合体内的功能对抗性.
- 使用患者队列识别下游转移抑制基因.
主要成果:
- 由TGFβ诱导的细胞迁移,入侵和转移被突变的p53促进,并被p63抑制.
- 结合Ras和突变p53的TGFbeta,便于组建一个突变p53/p63/Smad三元复合体.
- 在这个复合体内,p63的瘤抑制功能受到阻碍.
- 两种新的转移抑制基因,与乳腺癌患者转移风险相关,被确定为p63.3的下游基因.
结论:
- 突变的p53和Ras瘤基因创造了一个细胞环境,通过抑制p63.3来增强TGFbeta的转移性活动.
- 由TGFβ驱动的p63功能的抑制是促进癌细胞转移的一个关键步骤.
- 这些发现揭示了一种新的机制,将常见的瘤突变与TGFbeta介导的转移联系起来,并确定潜在的治疗点.
更多相关视频
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
相关概念视频
Abnormal Proliferation
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway